Susan G. Komen Breast Cancer Foundation – Trademark Portfolio
Entity Type: 99
Susan G. Komen Breast Cancer Foundation holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SHOOT FOR THE CURE. The owner is based in Dallas, TX.
Occidental Tower
5005 LBJ Freeway, Suite 370
Dallas, TX 75244
Showing of trademarks Trademarks
Trademark Classifications
Susan G. Komen Breast Cancer Foundation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Susan G. Komen Breast Cancer Foundation have?
Susan G. Komen Breast Cancer Foundation has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 3 cancelled.
What trademark classes does Susan G. Komen Breast Cancer Foundation file in?
Susan G. Komen Breast Cancer Foundation files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 16 (Paper Goods). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Susan G. Komen Breast Cancer Foundation's most well-known trademarks?
Susan G. Komen Breast Cancer Foundation's registered trademark portfolio includes well-known marks such as SHOOT FOR THE CURE. These are among 1 currently registered trademark in the portfolio.
What is Susan G. Komen Breast Cancer Foundation's trademark registration success rate?
Susan G. Komen Breast Cancer Foundation has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.